Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Warts × Imiquimod × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Keratosis, Actinic 10 Carcinoma, Basal Cell 4 Keratosis 2 Warts 1 Hutchinson's Melanotic Freckle 1 Facies 1 Condylomata Acuminata 1

Interventions

Cryotherapy 3 Cantharidin 2 green tea extract polyphenone E 1 ethyl pyruvate 1 compound W 1 Zinc 1 Trichloroacetic Acid 1 Salicylates 1 Measles-Mumps-Rubella Vaccine 1 Imiquimod 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00761371 2022-02-07

Imiquimod 5% Cream in the Treatment of External Genital or Perianal Warts in HIV+ Patients

Viatris Inc.

Phase 4 Completed

Warts

Data powered by HemOnc (CC BY 4.0) Colophon ⚡